Collier B, Johnson G, Quik M, Welner S
Br J Pharmacol. 1984 Aug;82(4):827-32. doi: 10.1111/j.1476-5381.1984.tb16479.x.
Rats were treated for 2-6 weeks with guanethidine after which their superior cervical ganglia were removed. Ganglionic tyrosine hydroxylase and alpha-bungarotoxin binding sites were reduced by the guanethidine treatment indicating adrenergic cell body destruction. Choline acetyltransferase activity and acetylcholine content of ganglia were not clearly changed by the guanethidine treatment, indicating that the drug does not destroy presynaptic terminals and that these presynaptic indicators do not adapt markedly to postsynaptic loss. The cholinesterase in the ganglia was reduced by guanethidine treatment, but such ganglia retained their ability to accumulate surplus acetylcholine when they were incubated with physostigmine. This is interpreted as indicating surplus acetylcholine accumulation is a presynaptic phenomenon. Choline uptake by resting ganglia was not reduced as a result of guanethidine treatment nor was it affected by preganglionic denervation. This is interpreted as indicating that during rest, choline uptake is into supporting cells or intraganglionic cells rather than cholinergic nerve terminals or adrenergic cell bodies.
用胍乙啶对大鼠进行2至6周的治疗,之后切除它们的颈上神经节。胍乙啶治疗使神经节酪氨酸羟化酶和α-银环蛇毒素结合位点减少,表明肾上腺素能细胞体被破坏。胍乙啶治疗并未明显改变神经节的胆碱乙酰转移酶活性和乙酰胆碱含量,这表明该药物不会破坏突触前终末,并且这些突触前指标不会因突触后损失而显著适应。胍乙啶治疗使神经节中的胆碱酯酶减少,但当这些神经节与毒扁豆碱一起孵育时,它们仍保留积累多余乙酰胆碱的能力。这被解释为表明多余乙酰胆碱的积累是一种突触前现象。胍乙啶治疗并未降低静息神经节对胆碱的摄取,节前去神经支配也未对其产生影响。这被解释为表明在静息状态下,胆碱摄取进入支持细胞或神经节内细胞,而非胆碱能神经终末或肾上腺素能细胞体。